Treatment of neurodegenerative disease
CA 2404858 A1 · Owner: Minerva Biotechnologies Corporation · Inventors: Bamdad, R. Shoshanna; Bamdad, Cynthia C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
In some aspects, the invention relates to treatments for peptide aggregation associated with disease states such as neurodegenerative disease particularly , physiology associated with Alzheimer's Disease and non-neurodegenerative , disease aggregation. Other aspects of the invention also provides a variety of novel assays for screening candidate drugs. Yet another aspects of the present invention also provides a series of compositions useful for treatment of neurological disease as determined from these assays. These compositions can be packaged in kits. Other aspects of the invention also relate to the use of these compositions for the treatment and/or prevention of patients …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 12, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 12, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 12, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.